Sensei Biotherapeutics Inc logo

Sensei Biotherapeutics Inc

NAS:SNSE (USA)   Ordinary Shares
$ 1.02 +0.0199 (+1.99%) 10:08 PM EST
At Loss
P/B:
0.39
Market Cap:
$ 25.57M
Enterprise V:
$ -34.48M
Volume:
6.16K
Avg Vol (2M):
91.15K
Also Trade In:
Volume:
6.16K
At Loss
Avg Vol (2M):
91.15K

Business Description

Sensei Biotherapeutics Inc logo
Sensei Biotherapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US81728A1088

Share Class Description:

SNSE: Ordinary Shares
Description
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
Name Current Vs Industry Vs History
Cash-To-Debt 10.59
Equity-to-Asset 0.87
Debt-to-Equity 0.1
Debt-to-EBITDA -0.19
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -23.7
3-Year EPS without NRI Growth Rate -20.6
3-Year FCF Growth Rate -21.6
Name Current Vs Industry Vs History
5-Day RSI 52.6
9-Day RSI 48.78
14-Day RSI 49.79
6-1 Month Momentum % 77.75
12-1 Month Momentum % -27.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.92
Quick Ratio 11.92
Cash Ratio 11.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 5.4
Shareholder Yield % 6.17
Name Current Vs Industry Vs History
ROE % -41.25
ROA % -36.13
ROIC % -306.29
ROC (Joel Greenblatt) % -402.66
ROCE % -38.76